Showing results (211-220 of 421) with videos related to

Sort By:
Pageof 43
Alcoholism, Clinical and Experimental Research|February 4, 2010
Prenatal alcohol exposure alters biobehavioral reactivity to pain in newbornsTim F Oberlander, Sandra W Jacobson, Joanne Weinberg, et al.
Plos One|November 21, 2012
Clinical, ethical and financial implications of incidental imaging findings: experience from a phase I trial in healthy elderly volunteersDavid J Pinato, Chara Stavraka, Mark Tanner, et al.
Allergy and Asthma Proceedings|October 3, 2012
C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of lifeAgaindra K Bewtra, Robyn J Levy, Kraig W Jacobson, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 9, 2024
Serological Markers of Clinical Improvement in MuSK Myasthenia GravisGregorio Spagni, Angela Vincent, Bo Sun, et al.
Biometrics|September 16, 2024
Semi-parametric benchmark dose analysis with monotone additive modelsAlex Stringer, Tugba Akkaya Hocagil, Richard J Cook, et al.
Neurotoxicology and Teratology|September 26, 2006
Magnetic resonance and spectroscopic imaging in prenatal alcohol-exposed children: preliminary findings in the caudate nucleusBernadette M Cortese, Gregory J Moore, Beth A Bailey, et al.
International Forum of Allergy & Rhinology|June 2, 2018
EXHANCE-12: 1-year study of the exhalation delivery system with fluticasone (EDS-FLU) in chronic rhinosinusitisJames N Palmer, Kraig W Jacobson, John C Messina, et al.
Environmental and Molecular Mutagenesis|January 1, 1997
Mutagenicity of HPLC-fractionated urinary metabolites from 2,4,6-trinitrotoluene-treated Fischer 344 ratsL R Brooks, R W Jacobson, S H Warren, et al.
Alcohol, Clinical & Experimental Research|March 30, 2024
Dose-response effect of prenatal alcohol exposure on perinatal outcomesLudmila N Bakhireva, Xingya Ma, Alexandria Wiesel, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|July 12, 2005
Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucoseD R Clemmons, A C Moses, A Sommer, et al.
Pageof 43